Stryker CorporationSYK recently announced the acquisition of HyperBranch Medical Technology for a deal value of $220 million in cash. The buyout is likely to boost Stryker's core Neurotechnology ...

Durham-based HyperBranch Medical Technology Inc. has raised $1.7 million in equity funding to help take a new surgical sealant device through the regulatory approval process. The six participating ...

Stryker Corporation SYK recently announced the acquisition of HyperBranch Medical Technology for a deal value of $220 million in cash. The buyout is likely to boost Stryker’s core ...

DURHAM, N.C. — HyperBranch Medical Technology, Inc. announced today that on June 8, 2018, after a two-week trial in federal district court in Wilmington, Delaware, an 8-member jury found in favor of ...

(“HyperBranch”) to Stryker Corporation (NYSE:SYK), one of the world’s leading medical technology companies, for a total equity value of approximately $220 million in an all cash transacti ...

The parties were not entitled to exclude expert testimony because the opinions were reasonably reliable, and summary judgment was proper as to the issue of whether a two-player market existed.

HyperBranch Medical of Durham, NC has won CE approval for its OcuSeal liquid ocular bandage, meaning it can be sold outside the U.S. OcuSeal is a liquid hydrogel polymer which becomes a ...

The FDA approved HyperBranch Medical Technology's Adherus AutoSpray Dural Sealant to provide watertight closure during cranial procedures, according to a March 30 approval letter. Approval came ...